News search

    E.g., 02/09/2026
    E.g., 02/09/2026
    Research
    2 Sep 2026
    European Journal of Heart Failure: A diabetes drug reduces complications after aortic valve replacement

    A new analysis of the DapaTAVI trial, published in the European Journal of Heart Failure, confirms that dapagliflozin improves outcomes after TAVI regardless of cardiac function.
    Research
    31 Mar 2025
    NEJM: A drug used to treat diabetes improves the prognosis of patients undergoing cardiac valve intervention

    The DapaTAVI study, conducted in 39 Spanish hospitals and coordinated by the CNIC, marks a breakthrough in cardiovascular research and could transform the treatment of these patients